Express Pharma

JANUARY 21, 2024

The exhibition sought to showcase the advancements in the pharma sector innovations and explore the latest trends and innovations.

86

86

Pharmaceutical Technology

APRIL 20, 2023

In the first phase of its training workshops, the Pharmaceutical Innovation Center plans to develop a range of excipients [inactive substances that serve as the vehicle or medium for a drug or other active substance] for controlled release dosage forms, improving their bioavailability, along with formulating orally dispersible and chewable tablets.

Dosage 52

Dosage 52

Express Pharma

APRIL 19, 2023

Planned topics for the first wave of training workshops include selecting excipients for controlled release dosage forms, enhancing bioavailability, and formulating effective orally dispersible and chewable tablets. Expert training, troubleshooting and scale-up advice will be priorities at the facility.

Dosage 52

Dosage Drug Development 52

Pharmaceutical Technology

JUNE 10, 2023

It is investigating its lead candidate, daxibotulinumtoxinA, a topical gel formulation as a needle-free approach for a wide range of therapeutic and aesthetic indications, such as chronic migraine, facial wrinkles and muscle disorders. Revance Therapeutics is headquartered in Nashville, Tennessee, the US.

Drug Development 52

Drug Development 52

Pharmaceutical Technology

JUNE 10, 2023

It is investigating its lead candidate, daxibotulinumtoxinA, a topical gel formulation as a needle-free approach for a wide range of therapeutic and aesthetic indications, such as chronic migraine, facial wrinkles and muscle disorders. Revance Therapeutics is headquartered in Nashville, Tennessee, the US.

Drug Development 52

Drug Development 52

Quality Matters

APRIL 25, 2024

India is poised to leverage the opportunities before it while also managing continued challenges to ensure the quality of both finished products and ingredients (including excipients).

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing 52

Quality Matters

JUNE 12, 2023

Examples of complex generics include enoxaparin injection, orlistat lipase inhibitor, acyclovir topical cream, and epinephrine auto-injector. In some cases, the therapeutic effect is delivered locally rather than systemically, or the mixture of components contains more than one active molecule.

Generic Medicine 52

Generic Medicine Dosage Prescription Filling Diabetes 52

Quality Matters

JUNE 8, 2023

The workshop touched on a wide range of topics – the sources of nitrosamines, analytical considerations, toxicity assessments and regulatory compliance. Earlier this year, Jaywant helped host a USP workshop in Hyderabad, India, conducted in collaboration with the IPA. What concerns did you hear from attendees?

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JANUARY 29, 2024

Conclusions Of the five major topics covered during 2023, it is likely that all will feature to a greater or lesser extent during 2024. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. Lessons learnt from presence of N-nitrosamine impurities in sartan medicines.

Drug Development 94

Drug Development Vaccines Compounding 94

Quality Matters

NOVEMBER 11, 2022

Contaminants can come from a drug substance, excipients (a drug’s inactive ingredients), solvents or water used in the process, product degradation during storage, or even in a product’s packaging. USP has also conducted survey research to seek feedback from industry to ensure that the solutions proposed by USP meet stakeholders’ needs.

Packaging 52

Packaging Documentation Compounding Diabetes 52

Express Pharma

SEPTEMBER 26, 2023

In this video: Dr Abhijit V Gothoskar, Formulation Expert, Sigachi Industries Topic: Enhancing pharma manufacturing capabilities Key Takeaway: Co-processed excipients offer a lot of advantages not offered by single excipients.

52

52

Express Pharma

JUNE 16, 2023

In this video: Dr Abhijit V Gothoskar, Formulation Expert, Sigachi Industries Topic: Enhancing pharma manufacturing capabilities Key Takeaway: Reducing number of unit operations can improve productivity. Co-processed excipients are more effective than single excipients. Sigachi can be the right partner to pharma formulators.

52

52

Quality Matters

OCTOBER 13, 2021

In addition to standards for active pharmaceutical ingredients, USP also develops standards for the inactive ingredients (excipients) and other raw materials used in drug manufacturing.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

GMPSOP

FEBRUARY 25, 2023

Sampling requirement for Critical and Non-Critical Excipients Critical excipient are raw materials that are defined as those directly added to final product formulation, whose function is as an adjuvant, preservative or an antioxidant. There should be no difference in sampling plans between actives and excipients.

Labelling 52

Labelling Packaging Documentation Pharmaceutical Manufacturing 52

RX Note

FEBRUARY 23, 2023

Introduction The purpose of this table of contents is to enable you to know clearly which topics are available in the blog, hence easing your learning process. Alternatively, you can also use the search feature at the top right corner. Ancora imparo: I am still learning.

HIV Treatment and Prevention Agents 75

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 75